| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 351532-07-5 | H-Tyr-Trp-Lys-NH2·2 HCl |
≥98% | | 询价 |
| 2 | 228544-21-6 | H-Tyr-Ser-Pro-Trp-Thr-Asn-Phe-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 122409-34-1 | H-Tyr-Pro-Pro-Trp-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 4 | 38678-75-0 | H-Tyr-Phe-NH2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 5 | 155943-09-2 | H-Tyr-Lys-Thr-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 6 | 281213-44-3 | H-Tyr-Leu-NH2·HCl |
≥98% | | 询价 |
| 7 | 3788-44-1 | H-Tyr-His-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 8 | 286458-87-5 | H-Tyr-Gly-Arg-Phe-Ser-OH·HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 9 | 1467829-71-5 | Durlobactam |
≥98% | | 询价 |
| 10 | 51410-30-1 | Pirenoxine sodium |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 11 | 88497-88-5 | Manassantin B |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 12 | 130656-51-8 | Nifekalant hydrochloride(MS-551) |
≥98% | | 询价 |
| 13 | 2484865-42-9 | Sec61-IN-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 14 | 943326-71-4 | Exeporfinium bromide(XF-73) |
≥98% | | 询价 |
| 15 | 194085-75-1 | (S)-Carisbamate |
≥98% | | 询价 |
| 16 | 2559703-06-7 | Apostatin-1(Apt-1) |
≥98% | | 询价 |
| 17 | 3625-06-7 | Mebavine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 18 | 70161-09-0 | Democonazole |
≥98% | | 询价 |
| 19 | 189744-46-5 | RO 10-5824 |
≥98% | | 询价 |
| 20 | 93460-55-0 | 8-Deacetyl yunaconitine |
≥98% | | 询价 |
| 21 | 107668-79-1 | Bulleyaconitine A |
≥98% | | 询价 |
| 22 | 1821370-64-2 | DIETHYL PYIMDC |
≥98% | | 询价 |
| 23 | 907952-06-1 | GPR34 modulator 1 |
≥98% | | 询价 |
| 24 | 201740-84-3 | L-LEUCINE-13C6 |
≥98% | | 询价 |
| 25 | 2416417-65-5 | MYF-01-37 |
≥98% | | 询价 |
| 26 | 384859-58-9 | BCH001 |
≥98% | | 询价 |
| 27 | 2314467-60-0 | TRPV4 agonist |
≥98% | | 询价 |
| 28 | 1092794-11-0 | ZINC-95803150 |
≥98% | | 询价 |
| 29 | 1210906-48-1 | ZINC30303842 |
≥98% | | 询价 |
| 30 | 897326-30-6 | DTHIB |
≥98% | | 询价 |
| 31 | 1403859-14-2 | CC-90001 |
≥98% | | 询价 |
| 32 | 566914-00-9 | IL-1R Antagonist |
≥98% | | 询价 |
| 33 | 2561476-24-0 | EMAC10101d |
≥98% | | 询价 |
| 34 | 2375815-63-5 | LY-3475070 |
≥98% | | 询价 |
| 35 | 29477-83-6 | Narciclasine |
≥98% | | 询价 |
| 36 | 2086257-77-2 | VBIT-4 |
≥98% | | 询价 |
| 37 | 2304621-31-4 | LDC195943(IMT1) |
≥98% | | 询价 |
| 38 | 2114651-20-4 | Ethyl 6-fluorobenzofuran-7-carboxylate |
≥98% | | 询价 |
| 39 | 2272976-28-8 | WEE1-IN-3 |
≥98% | | 询价 |
| 40 | 1473450-62-2 | NITD-349 |
≥98% | | 询价 |
| 41 | 1391934-98-7 | FIDAS-5 |
≥98% | | 询价 |
| 42 | 796888-12-5 | LCH-7749944 |
≥98% | | 询价 |
| 43 | 149709-44-4 | LBQ-657 sodium |
≥98% | | 询价 |
| 44 | 1683617-62-0 | Apcin A |
≥98% | | 询价 |
| 45 | 1888318-68-0 | CS-12192 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | | AEG-41174 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | | INCB-52793 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | 2412496-23-0 | Nezulcitinib(TD-0903) |
≥98% | | 询价 |
| 49 | 1237168-58-9 | Fosifidancitinib |
≥98% | | 询价 |
| 50 | 1236667-40-5 | Ifidancitinib(ATI-50002 ATI-502) |
≥98% | | 询价 |
| 51 | | INCB-047986 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | 1771691-34-9 | BMS-986202 |
≥98% | | 询价 |
| 53 | 2051918-33-1 | Izencitinib(TD-1473) |
≥98% | | 询价 |
| 54 | 2227392-55-2 | BSJ-01-175 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | 2044520-06-9 | VK-2019 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | 1384984-31-9 | Fobrepodacin(SPR-720) |
≥98% | | 询价 |
| 57 | 2332841-25-3 | TBAJ-876 |
≥98% | | 询价 |
| 58 | 2414418-49-6 | ZNL-02-096 |
≥98% | | 询价 |
| 59 | 2133417-13-5 | Ralmitaront(WHO-11130 RO-6889450 RG-7906) |
≥98% | | 询价 |
| 60 | 66516-09-4 | Mertiatide |
≥98% | | 询价 |
m.cnreagent.com